Remove 2018 Remove HIV Treatment and Prevention Agents Remove Patient Care
article thumbnail

FDA Approves Meloxicam Injection For Moderate-to-Severe Pain in Adults

Pharmacy Times

1 "[Meloxicam injection] demonstrates our commitment to improving patient care by providing an alternate dosage form for pain management," Ron Scarboro, chief executive officer at Azurity Pharmaceuticals, said in a press release. August 24, 2018. 2 REFERENCES 1. 2 REFERENCES 1. Schwenk E, Mariano E, et al. 18.00217 2.

FDA 73